ALNY vs CLMB · P/E 76, rev $1.29B vs P/E 27, rev $356.6M
Alnylam Pharmaceuticals Inc (ALNY) versus Climb Global Solutions (CLMB) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Climb Global Solutions (CLMB) is a electronics & computer distribution company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported CLMB revenue for 2026-06-30 was $356.6M. Net income was $8.9M. Revenue was up 95.5% from 2026-03-31 to 2026-06-30. CLMB currently screens at market cap $534.9M and trailing P/E 27.2.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. CLMB currently screens at market cap $534.9M and trailing P/E 27.2.
Not investment advice. Open the ALNY and CLMB stock pages for the full models.
Not investment advice.